Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834937 · ClinicalTrials.gov registry record
ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
A clinical trial, sponsored by InSightec.
- Terminated
- Registry status
- 17
- Enrollment target
NCT01834937: Clinical Trial study, sponsored by InSightec.
NCT01834937 is a clinical trial that was terminated before completion, run by InSightec. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834937 was terminated before completion, sponsored by InSightec.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this enhanced surveillance study ("ESS") is to collect information regarding chronic adverse events that are possibly related to the ExAblate® System ("ExAblate") that are received by InSightec ("InSightec") following PMA approval. This study will examine adverse events reported in patients undergoing the device procedure for the first two years of commercial experience. Other relevant data may be collected as well.
Primary Outcome
This study is designed to collect safety data during the first two years of commercial use of ExAblate MRgFUS treatment for palliation of pain resulting from bone metastases.
Interventions
- DEVICE ExAblate MRgFUS (Magnetic Resonance guided Focused Ultrasound Surgery)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-04 |
Why NCT01834937 stopped before completion
NCT01834937 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ExAblate MRgFUS (Magnetic Resonance guided Focused Ultrasound Surgery) is the first listed.
NCT01834937 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01834937 about?
NCT01834937 is a clinical study titled "ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain". The purpose of this enhanced surveillance study ("ESS") is to collect information regarding chronic adverse events that are possibly related to the ExAblate® System ("ExAblate") that are received by InSightec ("InSightec") following PMA approval. This study will examine adverse events reported in pa...
What is the current status of trial NCT01834937?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2013-06. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01834937?
The interventions under investigation include: ExAblate MRgFUS (Magnetic Resonance guided Focused Ultrasound Surgery) (DEVICE).
Who is sponsoring clinical trial NCT01834937?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia